2h7j: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
The substrate activity screening method, a substrate-based fragment, identification and optimization method for the development of enzyme, inhibitors, was previously applied to cathepsin S to obtain low nanomolar, 1,4-disubstituted-1,2,3-triazole-based aldehyde inhibitors (Wood, W. J., L.; Patterson, A. W.; Tsuruoka, H.; Jain, R. K.; Ellman, J. A. J. Am., Chem. Soc. 2005, 127, 15521-15527). Replacement of the metabolically, labile aldehyde pharmacophore with the nitrile pharmacophore provided, inhibitors with moderate potency for cathepsin S. The inhibitors showed, good selectivity over cathepsins B and L but no selectivity over cathepsin, K. X-ray structures of two crystal forms (1.5 and 1.9 A) of a complex, between cathepsin S and a triazole inhibitor incorporating a chloromethyl, ketone pharmacophore guided the design of triazole substrates with, increased cleavage efficiency and selectivity for cathepsin S over, cathepsins B, L, and K. Conversion of select substrates to nitrile, inhibitors yielded a low molecular weight (414 Da) and potent (15 nM), cathepsin S inhibitor that showed >1000-fold selectivity over cathepsins, B, L, and K.
The substrate activity screening method, a substrate-based fragment identification and optimization method for the development of enzyme inhibitors, was previously applied to cathepsin S to obtain low nanomolar 1,4-disubstituted-1,2,3-triazole-based aldehyde inhibitors (Wood, W. J. L.; Patterson, A. W.; Tsuruoka, H.; Jain, R. K.; Ellman, J. A. J. Am. Chem. Soc. 2005, 127, 15521-15527). Replacement of the metabolically labile aldehyde pharmacophore with the nitrile pharmacophore provided inhibitors with moderate potency for cathepsin S. The inhibitors showed good selectivity over cathepsins B and L but no selectivity over cathepsin K. X-ray structures of two crystal forms (1.5 and 1.9 A) of a complex between cathepsin S and a triazole inhibitor incorporating a chloromethyl ketone pharmacophore guided the design of triazole substrates with increased cleavage efficiency and selectivity for cathepsin S over cathepsins B, L, and K. Conversion of select substrates to nitrile inhibitors yielded a low molecular weight (414 Da) and potent (15 nM) cathepsin S inhibitor that showed >1000-fold selectivity over cathepsins B, L, and K.


==About this Structure==
==About this Structure==
Line 14: Line 14:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Ellman, J.A.]]
[[Category: Ellman, J A.]]
[[Category: Hornsby, M.]]
[[Category: Hornsby, M.]]
[[Category: Lesley, S.]]
[[Category: Lesley, S.]]
[[Category: Patterson, A.W.]]
[[Category: Patterson, A W.]]
[[Category: Spraggon, G.]]
[[Category: Spraggon, G.]]
[[Category: Wood, W.J.]]
[[Category: Wood, W J.]]
[[Category: H7J]]
[[Category: H7J]]
[[Category: P15]]
[[Category: P15]]
Line 27: Line 27:
[[Category: substrate activity screening]]
[[Category: substrate activity screening]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 17:30:20 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:39:00 2008''